Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val Gene Polymorphisms In Colorectal Cancer Patients: Relationships with Treatment Outcome
Authors:
- 17 December 2007
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 8 (12) , 1693-1703
Abstract
Introduction: Glutathione S-transferase P1 (GSTP1) and excision-repair cross-complementing repair deficiency group 2 protein (ERCC2 or XPD) may modulate the activity of platinum derivatives. The SNPs, Ile105Val for GSTP1 and Lys751Gln for ERCC2, may affect the efficiency of oxaliplatin in patients treated with an oxaliplatin-based regimen for metastatic colorectal carcinoma. Patients & Methods: A total of 107 patients treated with first-line chemotherapy, 59 with an oxaliplatin–based regimen and 48 with an irinotecan-based regimen, were included retrospectively. GSTP1 and ERCC2 genotypes were identified on DNA samples extracted from paraffin blocks containing either normal tissue (nodes) or tumor tissue. We analyzed treatment response, event-free and overall survival. Results: GSTP1 genotype distribution was Ile/Ile 58%, Ile/Val 35% and Val/Val 7%. ERCC2 genotype distribution was Lys/Lys 49%, Lys/Gln 44%, Gln/Gln 7%. Event-free and overall survivals were not significantly different as a function of the GS...Keywords
Funding Information
- Ligue Nationale Française contre le Cancer
This publication has 23 references indexed in Scilit:
- Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal CancerClinical Cancer Research, 2006
- Cancer incidence and mortality in Europe, 2004Annals of Oncology, 2005
- Surgical Therapy for Metastatic Disease to the LiverAnnual Review of Medicine, 2005
- Intensive Systemic Chemotherapy Combined With Surgery for Metastatic Colorectal Cancer: Results of a Phase II StudyJournal of Clinical Oncology, 2005
- Clinical anticancer drug development: targeting the cyclin-dependent kinasesBritish Journal of Cancer, 2004
- Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cellsBritish Journal of Cancer, 2004
- Relevance of Different UGT1A1 Polymorphisms in Irinotecan-Induced ToxicityClinical Cancer Research, 2004
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancerLung Cancer, 2002
- Treatment of Colorectal CancerDrugs, 1997